SLI
|
2 074,79
|
-11,15
|
-0,53 %
|
Analysen zu SLI-Werten
| 24.04.24 | Roche Equal Weight | Barclays Capital | |
| 24.04.24 | Novartis Buy | Deutsche Bank AG | |
| 24.04.24 | Roche Neutral | UBS AG | |
| 24.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 24.04.24 | Roche Hold | Jefferies & Company Inc. | |
| 24.04.24 | Roche Outperform | Bernstein Research | |
| 24.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | UBS Outperform | RBC Capital Markets | |
| 23.04.24 | Novartis Underweight | Barclays Capital | |
| 23.04.24 | Novartis Buy | UBS AG | |
| 23.04.24 | ABB Hold | Deutsche Bank AG | |
| 23.04.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 23.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 23.04.24 | UBS Underweight | Barclays Capital | |
| 22.04.24 | Richemont Buy | Goldman Sachs Group Inc. | |
| 19.04.24 | ABB Hold | Deutsche Bank AG | |
| 19.04.24 | ABB Sector Perform | RBC Capital Markets | |
| 19.04.24 | Zurich Insurance Overweight | Barclays Capital | |
| 19.04.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 18.04.24 | Roche Neutral | UBS AG | |
| 18.04.24 | Novartis Buy | UBS AG | |
| 18.04.24 | ABB Kaufen | DZ BANK | |
| 18.04.24 | Novartis Buy | Deutsche Bank AG | |
| 18.04.24 | ABB Market-Perform | Bernstein Research | |
| 18.04.24 | ABB Sector Perform | RBC Capital Markets | |
| 18.04.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 18.04.24 | ABB Hold | Jefferies & Company Inc. | |
| 18.04.24 | Givaudan Neutral | UBS AG | |
| 17.04.24 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 17.04.24 | Zurich Insurance Overweight | Barclays Capital | |
| 16.04.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 16.04.24 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 15.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 15.04.24 | Zurich Insurance Hold | Deutsche Bank AG | |
| 15.04.24 | ABB Sector Perform | RBC Capital Markets | |
| 15.04.24 | ABB Neutral | UBS AG | |
| 12.04.24 | ams-OSRAM Neutral | UBS AG | |
| 12.04.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 12.04.24 | Givaudan Neutral | JP Morgan Chase & Co. |